Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MAGNEsium With meToprolol for Rate Control In Atrial Fibrillation (MAGNETIC-AF)

NCT07632157 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.

NCT NCT07632157
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07632157 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MAGNEsium With meToprolol for Rate Control In Atrial Fibrillation (MAGNETIC-AF)
Lead sponsor
Wake Forest University Health Sciences
Phase
Phase 3
Overall status
Not yet recruiting
Start date
October 31, 2026
Completion date
December 31, 2028
Enrollment
196 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial flutter with rapid ventricular response